Sector
Biotech

Founders
Luca Emili

Insilicotrialsis working to bring a transition to the future of drug and medical device development, with online solutions that can reduce the cost and time of taking a new medical product through clinical trials. Trough the in silico technology, the company can increase the quality of life of millions of patients by allowing accessible treatments, bringing innovative drugs to the market faster, together with personalized cures and new solutions for rare diseases. The future of medicine lies in personalized treatments tailored to individual patient characteristics. Insilicotrials' computational modeling and simulation platform enables the healthcare revolution through user-friendly and integrated in silico nonclinical and clinical solutions.